News
Despite the many people praising medications like Ozempic, some are unaware of the potential issues that can arise from ...
Compounding pharmacies, that produced the weight loss drugs at a fraction of their brand name price, are being forced to stop ...
Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.
The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and ...
The FDA is cracking down on off brand weight loss products similar to Ozempic. GLP-1 drugs for weight loss like Wegovy or ...
Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...
A former head of the US Food and Drug Administration cut his body fat in half using GLP-1 drugs. In his book, he compares the ...
On February 21, 2025, the FDA updated its drug shortage list and labeled the shortage of all doses of injectable semaglutide (Ozempic/Wegovy ... compliant with FDA regulations and appropriately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results